Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on April 24, 2008

Arteriosclerosis, Thrombosis, and Vascular Biology. 2008
Published online before print April 24, 2008, doi: 10.1161/ATVBAHA.108.166041
A more recent version of this article appeared on July 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/7/1361    most recent
ATVBAHA.108.166041v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Fuhrman, B.
Right arrow Articles by Aviram, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuhrman, B.
Right arrow Articles by Aviram, M.

Submitted on November 29, 2007
Accepted on April 13, 2008

Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages via an NADPH Oxidase-Dependent Mechanism

Bianca Fuhrman *; Jasmin Khateeb ; Maayan Shiner ; Orna Nitzan ; Rachel Karry ; Nina Volkova ; and Michael Aviram

From the Lipid Research Laboratory (B.F., J.K., M.S., R.K., N.V., M.A.), Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences, and Rambam Medical Center, Haifa; and Internal Medicine Ward C (O.N.), Haemek Medical Center, Afula, Israel.

* To whom correspondence should be addressed. E-mail: Fuhrman{at}tx.technion.ac.il.

Objective—Macrophage foam cells are characterized by increased oxidative stress. Macrophage urokinase plasminogen activator (uPA) was shown to contribute to atherosclerosis progression. We hypothesized that uPA atherogenicity is related to its ability to increase macrophage oxidative stress. Increased macrophage oxidative stress in turn was shown to enhance PON2 expression. In the present study we investigated the effect of uPA on macrophage PON2 expression in relation to cellular oxidative stress.

Methods and Results—uPA increased PON2 expression in THP-1 macrophages in a dose-dependent manner. This effect required uPA/uPAR interaction and was abolished by cell treatment with antioxidants. uPA increased macrophage oxidative stress, measured by increased lipid peroxides, reactive oxygen species formation, superoxide anion release, and cell-mediated LDL oxidation. These effects were related to uPA-mediated activation of NADPH oxidase, and could not be reproduced in mouse peritoneal macrophages (MPM) harvested from p47phox-/- mice, suggesting a causal relationship between NADPH oxidase activation and the effects of uPA on macrophage oxidative stress and PON2 expression. Finally, MPM from PON2-/- mice were more susceptible to uPA-induced cellular oxidative stress than wild-type MPM, suggesting that PON2 protects against uPA-stimulated macrophage oxidative stress.

Conclusions—Upregulation of macrophage PON2 may provide a compensatory protective mechanism against uPA-stimulation of macrophage oxidative stress during atherogenesis.


Key words: urokinase • paraoxonase 2 (PON2) • macrophages • NADPH oxidase • antioxidants